Mats Anders Nilsson
Directeur Général chez KARESSA PHARMA HOLDING AB (PUBL)
Profil
Mats Anders Nilsson has worked as a Chief Executive Officer at Karessa Pharma Holding AB since 2018.
Postes actifs de Mats Anders Nilsson
| Sociétés | Poste | Début |
|---|---|---|
| KARESSA PHARMA HOLDING AB (PUBL) | Directeur Général | 01/01/2018 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Karessa Pharma Holding AB
 Karessa Pharma Holding AB Pharmaceuticals: MajorHealth Technology Karessa Pharma Holding AB engages in the development and commercialization of products in the therapeutic area of erectile dysfunction. Its patented drug is an alignate-based polymer film that is applied to the oral mucosa, which then rapidly delivered out into the bloodstream. The company was founded by Fredrik Hubinette on September 11, 2013 and is headquartered in Taby, Sweden. | Health Technology |
